Entasis Therapeutics Holdings Inc.
USD2.19
-0.01 (-0.45%)
CEO
Manoussos Perros
IPO Date
2018-09-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.19
Prev. Close
$2.20
Day Low
$2.19
Day High
$2.20
| 3 Mar 2022 |
| HC Wainwright & Co. |
| Buy |
| Neutral |
| downgrade |
| 19 Oct 2021 | BMO Capital | Outperform | Outperform | maintain |
| 18 Oct 2021 | HC Wainwright & Co. | Buy | Buy | maintain |
| 9 Sept 2020 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 13 Jul 2020 | Roth Capital | Buy | Buy | maintain |
| 13 Apr 2020 | H.C. Wainwright | Buy | Buy | maintain |
| 11 Mar 2020 | Credit Suisse | Outperform | Outperform | maintain |